AWM
Apollon Wealth Management’s Boston Scientific BSX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.67M | Buy |
24,826
+1,929
| +8% | +$207K | 0.05% | 294 |
|
|
2025
Q1 | $2.31M | Buy |
22,897
+2,542
| +12% | +$256K | 0.05% | 296 |
|
|
2024
Q4 | $1.82M | Buy |
20,355
+1,793
| +10% | +$160K | 0.04% | 358 |
|
|
2024
Q3 | $1.56M | Sell |
18,562
-394
| -2% | -$33K | 0.04% | 364 |
|
|
2024
Q2 | $1.46M | Sell |
18,956
-2,364
| -11% | -$182K | 0.04% | 360 |
|
|
2024
Q1 | $1.46M | Buy |
21,320
+597
| +3% | +$40.9K | 0.05% | 355 |
|
|
2023
Q4 | $1.2M | Buy |
20,723
+9,111
| +78% | +$527K | 0.04% | 396 |
|
|
2023
Q3 | $613K | Sell |
11,612
-1,361
| -10% | -$71.9K | 0.03% | 494 |
|
|
2023
Q2 | $702K | Sell |
12,973
-4,797
| -27% | -$259K | 0.03% | 507 |
|
|
2023
Q1 | $889K | Buy |
17,770
+1,821
| +11% | +$91.1K | 0.05% | 364 |
|
|
2022
Q4 | $738K | Sell |
15,949
-1,025
| -6% | -$47.4K | 0.05% | 388 |
|
|
2022
Q3 | $657K | Sell |
16,974
-2
| -0% | -$77 | 0.05% | 372 |
|
|
2022
Q2 | $633K | Sell |
16,976
-1,308
| -7% | -$48.8K | 0.05% | 373 |
|
|
2022
Q1 | $810K | Sell |
18,284
-2,275
| -11% | -$101K | 0.06% | 339 |
|
|
2021
Q4 | $873K | Buy |
20,559
+8,747
| +74% | +$371K | 0.07% | 313 |
|
|
2021
Q3 | $513K | Buy |
+11,812
| New | +$513K | 0.07% | 262 |
|
|
2020
Q3 | – | Sell |
-635
| Closed | -$22K | – | 221 |
|
|
2020
Q2 | $22K | Buy |
+635
| New | +$22K | 0.01% | 353 |
|